Weller M - Search Results

1

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

Rieger J, Lemke D, Maurer G, Weiler M, Frank B, Tabatabai G, Weller M, Wick W. Rieger J, et al. Among authors: weller m. J Neurochem. 2008 Sep;106(6):2436-48. doi: 10.1111/j.1471-4159.2008.05586.x. Epub 2008 Jul 24. J Neurochem. 2008. PMID: 18662322 Free article.

2

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

Roth W, Fontana A, Trepel M, Reed JC, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Cancer Immunol Immunother. 1997 Mar;44(1):55-63. doi: 10.1007/s002620050355. Cancer Immunol Immunother. 1997. PMID: 9111585 Free PMC article.

3

Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.

Wagenknecht B, Gulbins E, Lang F, Dichgans J, Weller M. Wagenknecht B, et al. Among authors: weller m. FEBS Lett. 1997 Jun 2;409(1):17-23. doi: 10.1016/s0014-5793(97)00468-7. FEBS Lett. 1997. PMID: 9199495 Free article.

4

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.

Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajewski S, Reed JC. Weller M, et al. Neurol Res. 1997 Oct;19(5):459-70. Neurol Res. 1997. PMID: 9329022

5

Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species.

Schulz JB, Bremen D, Reed JC, Lommatzsch J, Takayama S, Wüllner U, Löschmann PA, Klockgether T, Weller M. Schulz JB, et al. Among authors: weller m. J Neurochem. 1997 Nov;69(5):2075-86. doi: 10.1046/j.1471-4159.1997.69052075.x. J Neurochem. 1997. PMID: 9349553 Free article.

6

Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.

Weller M, Winter S, Schmidt C, Esser P, Fontana A, Dichgans J, Groscurth P. Weller M, et al. Int J Cancer. 1997 Nov 27;73(5):707-14. doi: 10.1002/(sici)1097-0215(19971127)73:5<707::aid-ijc16>3.0.co;2-2. Int J Cancer. 1997. PMID: 9398050

7

Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.

Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Br J Cancer. 1998;77(3):404-11. doi: 10.1038/bjc.1998.64. Br J Cancer. 1998. PMID: 9472635 Free PMC article.

8

CD95 ligand: lethal weapon against malignant glioma?

Weller M, Kleihues P, Dichgans J, Ohgaki H. Weller M, et al. Brain Pathol. 1998 Apr;8(2):285-93. doi: 10.1111/j.1750-3639.1998.tb00154.x. Brain Pathol. 1998. PMID: 9546287 Free PMC article. Review.

9

APO2 ligand: a novel lethal weapon against malignant glioma?

Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. Rieger J, et al. Among authors: weller m. FEBS Lett. 1998 May 1;427(1):124-8. doi: 10.1016/s0014-5793(98)00409-8. FEBS Lett. 1998. PMID: 9613612 Free article.

10

Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide.

Heneka MT, Löschmann PA, Gleichmann M, Weller M, Schulz JB, Wüllner U, Klockgether T. Heneka MT, et al. Among authors: weller m. J Neurochem. 1998 Jul;71(1):88-94. doi: 10.1046/j.1471-4159.1998.71010088.x. J Neurochem. 1998. PMID: 9648854 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,713 results

Search Page

Filters